Mangoceuticals
MGRX
18 hedge funds and large institutions have $456K invested in Mangoceuticals in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
53% more capital invested
Capital invested by funds: $298K → $456K (+$158K)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
6.99% more ownership
Funds ownership: 0% → 6.99% (+7%)
0% more funds holding
Funds holding: 18 → 18 (0)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$131K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$66.7K |
| 3 |
HF
HRT Financial
New York
|
+$13.9K |
| 4 |
AA
ACT Advisors
Asheville,
North Carolina
|
+$10.4K |
| 5 |
AG
AmeriFlex Group
Las Vegas,
Nevada
|
+$1.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$26.2K |
| 2 |
VF
Virtu Financial
New York
|
-$22K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$14.7K |
| 4 |
SG
StoneX Group
New York
|
-$5.78K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.18K |
MGRX Hedge Fund Activity: Q2 2026 in Review
18 of the 8,325 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q2 2026, worth a combined $456K — up 53% from $298K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MGRX positions and 4 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $131K. The largest seller was Jane Street, exiting entirely with an estimated $26.2K sold.
- 18 institutional investors held Mangoceuticals (MGRX) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $456K of Mangoceuticals stock for Q2 2026, up 53% quarter-over-quarter.
- 5 funds opened new Mangoceuticals positions in Q2 2026 and 4 closed out, a net change of +1 holder.
- The largest Mangoceuticals buyer in Q2 2026 was Citadel Advisors, an estimated $131K added.
- The largest Mangoceuticals seller in Q2 2026 was Jane Street, an estimated $26.2K sold.
Based on aggregated 13F filings for Q2 2026.